Division of Pediatric Behavioral Health, National Jewish Health, Denver, Colorado2University of Colorado, Denver.
Kaiser Permanente Colorado Institute for Health Research, Denver.
JAMA Pediatr. 2015 Apr;169(4):317-23. doi: 10.1001/jamapediatrics.2014.3280.
Most patients with asthma take fewer than half of prescribed doses of controller medication. Interventions to improve adherence have typically been costly, impractical, and at best only minimally successful.
To test a speech recognition (SR) intervention to improve adherence to pediatric asthma controller medication.
DESIGN, SETTING, AND PARTICIPANTS: The Breathe Well study was a 24-month pragmatic randomized clinical trial. The study was conducted within Kaiser Permanente Colorado, a large, group-model health maintenance organization. A total of 1187 children aged 3 to 12 years with a persistent asthma diagnosis and prescription for an inhaled corticosteroid were randomized to the computerized SR intervention or usual care condition and followed up for 24 months between October 2009 and February 2013.
Speech recognition telephone calls to parents in the intervention condition were triggered when an inhaled corticosteroid refill was due or overdue. Calls were automatically tailored with medical and demographic information from the electronic health record and from parent answers to questions in the call regarding recent refills or a desire to receive help refilling, learn more about asthma control, or speak with an asthma nurse or pharmacy staff member.
Adherence to pediatric asthma controller medication, measured as the medication possession ratio over 24 months.
In the intention-to-treat analysis, inhaled corticosteroid adherence was 25.4% higher in the intervention group than in the usual care group (24-month mean [SE] adherence, 44.5% [1.2%] vs 35.5% [1.1%], respectively; P < .001). Asthma-related urgent care events did not differ between the 2 groups. The intervention effect was consistent in subgroups stratified by age, sex, race/ethnicity, body mass index, and disease-related characteristics.
The intervention's significant impact on adherence demonstrates strong potential for low-cost SR adherence programs integrated with an electronic health record. The absence of change in urgent care visits may be attributable to the already low number of asthma urgent care visits within Kaiser Permanente Colorado. Application of electronic health record-leveraged SR interventions may reduce health care utilization when applied in a population with less-controlled asthma.
clinicaltrials.gov Identifier: NCT00958932.
大多数哮喘患者服用的控制器药物剂量不到处方剂量的一半。为提高依从性而采取的干预措施通常成本高昂、不切实际,且至多只能取得最小程度的成功。
测试语音识别 (SR) 干预措施以提高儿科哮喘控制器药物的依从性。
设计、设置和参与者:Breathe Well 研究是一项为期 24 个月的实用随机临床试验。该研究在 Kaiser Permanente Colorado 进行,这是一家大型团体模式健康维护组织。共有 1187 名年龄在 3 至 12 岁之间、持续哮喘诊断和吸入皮质类固醇处方的儿童被随机分配到计算机化的 SR 干预组或常规护理组,并在 2009 年 10 月至 2013 年 2 月期间进行了 24 个月的随访。
当吸入皮质类固醇需要补充或已经过期时,干预组的父母会接到语音识别电话。电话会根据电子健康记录中的医疗和人口统计学信息以及父母在电话中回答的关于最近补充或希望获得补充帮助、更多了解哮喘控制、或与哮喘护士或药剂师交谈的问题,自动定制。
儿科哮喘控制器药物的依从性,以 24 个月的药物持有率衡量。
在意向治疗分析中,干预组吸入皮质类固醇的依从性比常规护理组高 25.4%(24 个月平均 [SE] 依从率分别为 44.5% [1.2%]和 35.5% [1.1%];P < .001)。两组哮喘相关紧急护理事件无差异。该干预效果在按年龄、性别、种族/民族、体重指数和疾病相关特征分层的亚组中一致。
该干预措施对依从性的显著影响表明,与电子健康记录相结合的低成本语音识别依从性计划具有很大的潜力。紧急护理就诊次数没有变化可能归因于 Kaiser Permanente Colorado 内哮喘紧急护理就诊次数已经较少。在控制较差的人群中应用基于电子健康记录的语音识别干预措施可能会降低医疗保健的利用率。
clinicaltrials.gov 标识符:NCT00958932。